SOURCE: Neurogenesis, Inc.

October 28, 2013 08:30 ET

NeuroGenesis Dietary Supplement, NeuSlim, Sells Into a $11.5 Billion US Market

LEAGUE CITY, TX--(Marketwired - October 28, 2013) - NeuroGenesis, Inc. (PINKSHEETS: NEUN) -- In addition to our Neu BeCalm'd supplement, NeuroGenesis offers NeuSlim to the dietary supplement market, which aids in the reduction of cravings (or urges) for simple carbohydrates such as sugar and has been reported to reduce excessive appetite in general and assist in healthy moderation of nutritional needs. We believe we have a unique product that addresses a $11.5 Billion market (figures for 2012) which is forecasted to reach $15.5 billion by 2017. 

In our previous released news releases we stated that our products are available through 300 US hospitals and drug rehab centers. The corrected number should read as: With over 30 years of scientific research, studies, clinicals and use in over 1,700 US hospitals and drug rehab centers as a supplement, Neu BeCalm'd is shown to help replenish brain nutrients consumed by stress and restore healthy brain function.


After additional intense research, NeuroGenesis, a supplement formulator discovered that the Neu BeCalm'd approach is the most effective means of providing a long lasting solution to chemical imbalances in the brain. While most types of traditional medicine treat the symptoms, the Neu BeCalm'd product addresses the underlying issues in order help one achieve a normal life. In addition, the Neu BeCalm'd formulation contains FDA approved nutritional ingredients. Neu BeCalm'd has been reported to be beneficial in reducing the effects of acute as well as chronic stress factors in those who use the product.

Neu BeCalm'd is a safe, all natural alternative to traditional medicine, and is intended for people with PTSD and other similar problems. In addition, Neu BeCalm'd contains formulations of vitamins, minerals and amino acids that are designed to assist the brain in balancing and rebuilding neurotransmitters to achieve and maintain a chemical balance.

Forward-looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, which contain words such as "expect," "believe" or "plan," by their nature address matters that are, to different degrees, uncertain. These uncertainties may cause actual future events to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.

Contact Information